NCT00404378
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Lenexa, Kansas, United States
Clinical trial condition
Vomiting
Explore clinical trials studying Vomiting. Study availability and eligibility vary by location and protocol.
542 public trials
47 recruiting studies
Vomiting trial results
NCT00405080
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Tacoma, Washington, United States
NCT00431236
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Capital Federal, Buenos Aires, Argentina
- GSK Investigational Site Córdoba, Córdoba Province, Argentina
- GSK Investigational Site Rosario, Santa Fe Province, Argentina
- GSK Investigational Site San Miguel de Tucumán, Argentina
NCT00404274
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Gainesville, Florida, United States
- GSK Investigational Site Buffalo, New York, United States
Completed
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer
NCT00253708
- Conditions
- Adenocarcinoma, Adnexal Diseases, Behavior, +77 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Completed
The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
NCT00440128
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Hot Springs, Arkansas, United States
- GSK Investigational Site Iowa City, Iowa, United States
- GSK Investigational Site Detroit, Michigan, United States
- GSK Investigational Site Lebanon, New Hampshire, United States
NCT00358813
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +8 more
- Locations
-
- GSK Investigational Site Miramar, Florida, United States
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site Minneapolis, Minnesota, United States
NCT00460707
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
- GSK Investigational Site Buffalo, New York, United States
- GSK Investigational Site Columbus, Ohio, United States
NCT00511823
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Evansville, Indiana, United States
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +14 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States